Celldex Therapeutics, Inc. ( CLDX) - Key Metrics
CLDX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.94 | -$0.74 | -$0.78 |
| 2026Q1 | $0 | -$1.18 | -$0.99 | -$1.01 |
| 2025Q4 | $0 | -$1.22 | -$0.96 | -$0.98 |
| 2025Q3 | $0 | -$1.01 | -$0.73 | -$0.74 |
| 2025Q2 | $0.01 | -$0.85 | -$0.66 | -$0.67 |
CLDX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -9.90 |
| 2026Q1 | 0% | -6.72 |
| 2025Q4 | 0% | -5.52 |
| 2025Q3 | 0% | -6.40 |
| 2025Q2 | 0% | -5.99 |
CLDX
Price: $41.95
52 week price:
Earnings Per Share: -4.35 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 345800
Ebitda: -30.7 millionMarket Capitalization: 3.5 billion